,,iv  #aad? ,,congress  #a/ ,session    
,h4 ,,con4 ,,res4 #df  ,,9 ,,! ,,h\se   
,,( ,,repres5tatives  ,may #ad1 #bjae   
,mr4 ,pitts submitt$ ! foll[+ concurr5t 
resolution2 :i* 0 ref]r$ to ! ,committee
 on ,en]gy & ,comm]ce  ,,concurr5t      
,,resolution  ,express+ ! s5se ( !      
,congress t ! ,national ,in/itutes (    
,heal? %\ld enc\rage a global p$iatric  
cl9ical trial network1 & = o!r purposes4
  ,t x is ! s5se ( ! ,congress t-- 7#a7 
! ,national ,in/itutes ( ,heal? %\ld    
enc\rage a global p$iatric cl9ical trial
 network ?r\gh ! allocation ( grants1   
contracts1 or coop]ative agreem5ts to   
supplem5t ! sal>ies ( new & e>ly        
inve/igators :o p>ticipate 9 ! global   
p$iatric cl9ical trial network2  7#b7   
,national ,in/itutes ( ,heal? grants1   
contracts1 or coop]ative agreem5ts %\ld 
be aw>d$1 solely = ! purpose (          
supplem5t+ ! sal>ies ( new & e>ly       
inve/igators1 to entities t p>ticipate 9
 ! global p$iatric cl9ical trial        
network2  7#c7 ! ,food & ,drug          

,adm9i/ration %\ld engage ! ,european   
,m$ic9es ,ag5cy & o!r =eign regulatory  
entities dur+ ! =mation ( ! global      
p$iatric cl9ical trials network to      
enc\rage _! p>ticipation2 &  7#d7 once a
 global p$iatric cl9ical trial network  
is e/abli%$ & becomes op]ational1 !     
,food & ,drug ,adm9i/ration %\ld cont9ue
 to engage ! ,european ,m$ic9es ,ag5cy &
 o!r =eign regulatory entities to       
enc\rage & facilitate _! p>ticipation 9 
! network ) ! goal ( enhanc+ ! global   
rea* ( ! network4